Anmol Gulati
6PUBLICATIONS
23CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 30, 2026
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson's Disease.Elsie C Yu, Hua Zhou, Xin Yan
|Oct 20, 2023
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease.Solomon D Kattar, Anmol Gulati, Kaila A Margrey
|Dec 08, 2022
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1<i>H</i>-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease.David A Candito, Vladimir Simov, Anmol Gulati
|Dec 30, 2021
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors.Mitchell H Keylor, Anmol Gulati, Solomon D Kattar
|Aug 06, 2021
Optimization of brain-penetrant picolinamide derived leucine-rich repeat kinase 2 (LRRK2) inhibitors.Anmol Gulati, Charles S Yeung, Blair Lapointe
Pageof 1
Frequent Collaborators
3 joint publications
Dong Xiao
3 joint publications
Mitchell H Keylor
2 joint publications
Erin F DiMauro
2 joint publications
Jack D Scott
2 joint publications
Xin Yan
2 joint publications
Ellen C Minnihan
2 joint publications
Michael J Ardolino
2 joint publications
Charles A Lesburg
2 joint publications
David Jonathan Bennett
2 joint publications
Solomon Kattar
